CliffBio
small molecule

UZEDY

RISPERIDONE

Loss of exclusivityMarch 2042latest FDA-listed patent expiry
CompanyTEVA NEUROSCIENCE INC

Drug detail

Brand nameUZEDY
Active ingredientRISPERIDONE
Strength250MG/0.7ML (250MG/0.7ML)
Dosage formSUSPENSION, EXTENDED RELEASE
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalApril 2023
Marketing statusRX

Listed patents

PatentExpiresType
12329851March 2042use U-4214
12383493September 2040product
12128132September 2040product
9023897April 2033product
8221778November 2027product
8741327November 2027product

Regulatory exclusivity

CodeExpires
NPApril 2026

More from TEVA NEUROSCIENCE INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.